Lisa Henderson

Pharma should take an integrated approach to representing cultural elements in materials.

Ted Schroeder, CEO of Nabriva Therapeutics, is passionate in his forward-thinking approach to finding the next generation of anti-infectives, as resistance to least-expensive, tried-and-true therapies continues to grow.

Employer-sponsored health plans create an increasingly cloudy path to access.

COVID pandemic brings increased attention to other infectious diseases.

While pharma has reached new heights in vaccine development, many questions remain around the lasting effects of COVID and how future therapies can curb them.

Recognizing leadership in pharma.

Examining the incumbent and imminent workforce.

Latest disease-modifying market entrant for SMA addresses administration, access gaps.

Pharm Exec profiles five recent drug launches and announces winners of first annual APEX Awards.

Looking Back at 2003–2006.

Still plenty to learn about the virus even after year-plus long pandemic

Influenced by lessons from the playing field, former rugby athlete James Robinson, today president and CEO of Urovant Sciences, discusses the keys to establishing a high-performing team culture in biopharma—and the end-game wins in treatment gain and patient need.

Recent roundtable highlights need for biopharma to enter ESG conversation.

Past lessons, strong resolve, and complex coordination propel J&J’s vaccine efforts.

Building on a lifelong passion for biomedical research, and then its application in policy and health equity as a leader in various interconnected settings, Michelle McMurry-Heath, president and CEO of BIO, is uniquely positioned as a “translator” for science and social advocacy—and speaking stakeholders to action.

Combined powers of synbio and biopharma point to bright future for industry.

Our editorial team presents the winners of our annual Emerging Pharma Leaders and their up-and-coming perspectives on a range of industry topics.

Bridging science and business with the end user in mind.

Throwback scientist and entrepreneur leads quest to maximize gains in population health.

Pharm Exec's 2021 class of EPL winners showcase the many career trajectories through biopharma.

Ethics and diversity on full display across pharma industry.

Building on early achievements as a research scientist and drug inventor, Rod MacKenzie, today the leader of global product development at Pfizer—and latest HBA Honorable Mentor—has devoted much of his career to helping others succeed, including advancing efforts to break down gender barriers in pharma.

Industry makes large investments toward public health issues exposed by pandemic.

Not to be outdone by the showbiz industry, Pharm Exec's own awards season is fast approaching.

Embracing the new, holistic views of pharma in 2021.

2020 has proven to be a year like no other for pharma. Here is a quick look back at some of the trends 2020 created for the industry.

Chief financial officers gather virtually to share the stories of directing their company IPOs over the finish line amid the COVID-19 pandemic.

A brief look into how the Gene Editing Institute researching the diversity of responses in African-American regenerative cells to various forms of CRISPR.

Previewing executive trends thought of by leaders in the pharma industry.